No abstract available
MeSH terms
-
Benzhydryl Compounds / adverse effects*
-
Benzhydryl Compounds / therapeutic use
-
Diabetes Mellitus, Type 2 / complications*
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetic Ketoacidosis / diagnosis*
-
Diabetic Ketoacidosis / etiology
-
Diabetic Ketoacidosis / physiopathology
-
Female
-
Glucosides / adverse effects*
-
Glucosides / therapeutic use
-
Humans
-
Hypoglycemic Agents / adverse effects*
-
Hypoglycemic Agents / therapeutic use
-
Insulin / therapeutic use
-
Middle Aged
-
Sodium-Glucose Transporter 2
-
Sodium-Glucose Transporter 2 Inhibitors*
-
Treatment Outcome
Substances
-
Benzhydryl Compounds
-
Glucosides
-
Hypoglycemic Agents
-
Insulin
-
SLC5A2 protein, human
-
Sodium-Glucose Transporter 2
-
Sodium-Glucose Transporter 2 Inhibitors
-
empagliflozin